Abstract
During early embryonic development in mammals, including humans and mice, megakaryocytes (Mks) first originate from primitive hematopoiesis in the yolk sac. These embryonic Mks (eMks) circulate in the vasculature with unclear function. Herein, we report that podoplanin (PDPN), the ligand of C-type lectin-like receptor (CLEC-2) on Mks/platelets, is temporarily expressed in neural tissue during midgestation in mice. Loss of PDPN or CLEC-2 resulted in aneurysms and spontaneous hemorrhage, specifically in the lower diencephalon during midgestation. Surprisingly, more eMks/platelets had enhanced granule release and localized to the lower diencephalon in mutant mouse embryos than in wild-type littermates before hemorrhage. We found that PDPN counteracted the collagen-1–induced secretion of angiopoietin-1 from fetal Mks, which coincided with enhanced TIE-2 activation in aneurysm-like sprouts of PDPN-deficient embryos. Blocking platelet activation prevented the PDPN-deficient embryo from developing vascular defects. Our data reveal a new role for PDPN in regulating eMk function during midgestation.
| Original language | English |
|---|---|
| Pages (from-to) | 2756-2769 |
| Number of pages | 14 |
| Journal | Blood |
| Volume | 137 |
| Issue number | 20 |
| DOIs | |
| State | Published - May 20 2021 |
Bibliographical note
Publisher Copyright:© 2021 American Society of Hematology
Funding
The authors thank James George for critical comments, and the Imaging Core Facility of the Oklahoma Medical Research Foundation for tissue processing and electron microscopy. The study is supported by National Institutes of Health (NIH), National Heart, Lung, and Blood Institute grants HL128390, HL149860, HL153728 (L.X.), HL134210 (C.H.), and HL133668 (W.B.); NIH, National Institute of Child Health and Human Development grant HD083418 (L.X.); and NIH, National Institute of General Medical Sciences grant GM114731 (R.P.M.). The study is supported by National Institutes of Health (NIH), National Heart, Lung, and Blood Institute grants HL128390, HL149860, HL153728 (L.X.), HL134210 (C.H.), and HL133668 (W.B.); NIH, National Institute of Child Health and Human Development grant HD083418 (L.X.); and NIH, National Institute of General Medical Sciences grant GM114731 (R.P.M.).
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | |
| National Heart, Lung, and Blood Institute (NHLBI) | HL128390, HL134210, HL149860, HL133668, HL153728 |
| National Institute of General Medical Sciences DP2GM119177 Sophie Dumont National Institute of General Medical Sciences | GM114731 |
| NIH National Institute of Child Health and Human Development National Center for Medical Rehabilitation Research | R01HD083418 |
| Oklahoma Medical Research Foundation |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology